Publications by authors named "Ann R Falsey"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

723

Total Likes

305

Extended Reach

1,493,724

Social Features

376
S
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey

N Engl J Med· December 2020

Videos about Article: user user

2 50 374 13 1 6 3

View All Article and Social Media Activity
B
Burden and severity of respiratory syncytial virus infection in adults with cardiovascular diseases: A systematic literature review.
Yolanda Penders, Ann R Falsey, Deepak L Bhatt, Michael Böhm, Andrew J S Coats

Prog Cardiovasc Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A four-gene signature from blood to exclude bacterial etiology of lower respiratory tract infection in adults.
Ann R Falsey, Derick R Peterson, Edward E Walsh, Soumyaroop Bhattacharya, Andrea M Baran

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection.
Edward E Walsh, Michael Peasley, Angela R Branche, Ann R Falsey

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection by Nasopharyngeal Swabs Alone Underestimates Respiratory Syncytial Virus-Related Hospitalization Incidence in Adults: The Multispecimen Study's Final Analysis.
Elizabeth Begier, Negar Aliabadi, Julio A Ramirez, Allison McGeer, Qing Liu, Ann R Falsey

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.
Paul Spearman, Hong Jin, Peng Xiao, Kristeene Knopp, Henry Radziewicz, Ann R Falsey

Sci Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features and Gene Expression Patterns in Adults Hospitalized With Respiratory Syncytial Virus and Human Metapneumovirus Infection.
Colin Samoriski, Chin-Yi Chu, Ann R Falsey, Derick Peterson, Soumyaroop Bhattacharya

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Syncytial Virus Risk Assessment in Adults: Implications for Vaccine Recommendations Beyond Age.
Angela R Branche, Ann R Falsey, Lisa Saiman, Luis Alba, Derick Peterson

Open Forum Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for RSV Disease Aged 18 to 59 Years.
Erick F Mayer, Ann R Falsey, Rebecca Clark, Murdo Ferguson, Jose Cardona

Clin Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized with RSV.
Paulina Sudnik, Edward E Walsh, Angel R Branche, Md Islam, Ann R Falsey

Clin Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambient air pollution exposure and effects on neutralizing antibody titers following SARS-CoV-2 vaccination in adults.
Daniel P Croft, Carl J Johnston, Angela R Branche, David Q Rich, Philip K Hopke, Ann R Falsey

PLOS Glob Public Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.
Leah I B Andrews, M Elizabeth Halloran, Kathleen M Neuzil, Lars van der Laan, Yunda Huang, Ann R Falsey

JAMA Netw Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Vaccine Coadministration Is Safe, Effective, and Acceptable: Results of a Survey of the Literature.
Litjen Tan, Dana Trevas, Ann R Falsey

Influenza Other Respir Viruses· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic Complications of Influenza and Potential Protective Vaccine Effects.
Ann R Falsey

Influenza Other Respir Viruses· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Youyi Fong, Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Ann R Falsey

Clin Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Seasonal Vaccines for Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and Other Pathogens.
David Dobrzynski, Angela R Branche, Ann R Falsey

J Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.
Yolanda Penders, Guy Brusselle, Ann R Falsey, Gernot Rohde, Estefania Betancur

Curr Allergy Asthma Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults.
Catherine A Panozzo, Edward E Walsh, Zhen Yang, Eleanor Wilson, Jaya Goswami, Ann R Falsey

Infect Dis Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
Bo Zhang, Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Ann R Falsey

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
Holly Janes, Leigh H Fisher, Jia Jin Kee, Lalitha Parameswaran, Paul A Goepfert, Ann R Falsey

J Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory Syncytial Virus Hospitalization.
Angela R Branche, Ann R Falsey, Lyn Finelli, Edward E Walsh

J Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-Term Immunogenicity of Licensed Subunit RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) Compared to Community-Dwelling Older Adults.
Ann R Falsey, Angela R Branche, Michael Peasley, Mary Cole, Kim K Petrone

J Am Med Dir Assoc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.
Edward E Walsh, Gonzalo Pérez Marc, Ann R Falsey, Qin Jiang, Daniel Eiras

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and immunogenicity of Ad26.RSV.preF-RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study.
Ann R Falsey, Tessa Hosman, Arangassery Rosemary Bastian, Sjouke Vandenberghe, Eric K H Chan

Lancet Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.
Kathryn Shoemaker, Karina Soboleva, Angela Branche, Shivanjali Shankaran, Deborah A Theodore, Ann R Falsey

Vaccines (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity.
Ann Marie Stanley, Anastasia A Aksyuk, Deidre Wilkins, Justin A Green, Dongmei Lan, Ann R Falsey

Front Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis